Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01341444 · ClinicalTrials.gov registry record · NA
The Use of the Prevena Incision Management System (PIMS) on Closed Incisions in Renal Transplant Subjects
A NA study, sponsored by KCI USA.
- Terminated
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT01341444 is a NA study that was terminated before completion, run by KCI USA. The registered enrollment target is 63 participants.
The verdict
NCT01341444, a NA study, was terminated before completion, sponsored by KCI USA.
- TERMINATED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
This study is being conducted to see how safe and effective the Prevena Incision Management System "Prevena" is when placed over a renal transplantation incision. Prevena provides negative pressure (suction) wound therapy. Prevena will be tested while applied during the time each subject is hospitalized and up to 5 days after the surgery. Prevena is a small portable negative pressure device which consists of a therapy unit that delivers negative pressure. It also includes a dressing system that is intended for use over closed incisions after surgery. The intent of this study is to evaluate Prevena versus the standard care that a doctor would use normally after a kidney transplant.
Interventions
- DEVICE Prevena Incision Management System
- OTHER Standard of Care for Surgical Incisions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01341444
The ClinicalTrials.gov registry entry for NCT01341444 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is KCI USA, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prevena Incision Management System is the first listed.
NCT01341444 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01341444 about?
NCT01341444 is a clinical study titled "The Use of the Prevena Incision Management System (PIMS) on Closed Incisions in Renal Transplant Subjects". This study is being conducted to see how safe and effective the Prevena Incision Management System "Prevena" is when placed over a renal transplantation incision. Prevena provides negative pressure (suction) wound therapy. Prevena will be tested while applied during the time each subject is hospital...
What is the current status of trial NCT01341444?
This trial is currently terminated. It is a NA study. The enrollment target is 63 participants. The study started on 2013-08. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01341444?
The interventions under investigation include: Prevena Incision Management System (DEVICE), Standard of Care for Surgical Incisions (OTHER).
Who is sponsoring clinical trial NCT01341444?
This trial is sponsored by KCI USA, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.